The UK Stroke Forum 2017 took place this week at the ACC in Liverpool.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
This study will investigate how other illnesses can affect stroke treatment and outcome. It will involve the analysis of electronic, linked datasets of health information from stroke patients in Scotland.
Published online (ahead of print in the journal Annals of Neurology), the results of a new study found that one year after arterial ischaemic stroke (AIS), the rate of death, recurrence of stroke, and neurological impairment was lower than reports in previous studies.
The World Stroke Organization (WHO) reclassify stroke and vascular dementia for the next International Classification of Diseases (ICD).
Can stem cells be used to reduce the damage of inflammation after stroke and promote brain repair?
The effect of blood pigments on brain inflammation and survival of nerve cells.
How important is the relationship between therapist and stroke survivor in the rehabilitation of language ability?
Can a drug commonly used for gout improve recovery and prevention of further stroke for stroke survivors?
Identifying how best to combine results from several clinical trials of a stroke rehabilitation treatment.